How to be successful in the drug market
The Sport Biblical offers an in-depth look at how to become a successful pharmaceutical drugmaker in the U.S. The book includes an in depth look at some of the biggest pharma companies in the world, including Bayer, Johnson & Johnson, AstraZeneca, Pfizer, Astrazeneca and Astra Zeneca.
“Drug companies are not the only ones making money in the pharmaceutical market.
Drug companies are often the first to make a decision, so the rest of the industry needs to make its own decisions,” said Jeffery N. Nevin, chairman of Nevin Strategic Consulting.
“Most pharmaceutical companies don’t get to make the first decision on the pricing of a drug or a new drug.
The decision on whether to pursue a new therapy is made by the drug company itself, not by the FDA.
This is one reason why drug companies are reluctant to go out and spend billions of dollars on new drugs and how much that costs them.
So they are likely to stay focused on making as many drugs as they can.”
The Sport Bible offers a look at what drug companies have done to stay ahead of the competition, including: The number of new drugs approved for the market in 2016: 731, down from 1,532 in 2015;